Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile
- 30 April 2010
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 107 (20), 9352-9357
- https://doi.org/10.1073/pnas.0913554107
Abstract
The last decade has seen numerous outbreaks of Clostridium difficile-associated disease (CDAD), which presented significant challenges for healthcare facilities worldwide. We have identified and purified thuricin CD, a two-component antimicrobial that shows activity against C. difficile in the nanomolar range. Thuricin CD is produced by Bacillus thuringiensis DPC 6431, a bacterial strain isolated from a human fecal sample, and it consists of two distinct peptides, Trn-α and Trn-β, that act synergistically to kill a wide range of clinical C. difficile isolates, including ribotypes commonly associated with CDAD (e.g., ribotype 027). However, this bacteriocin thuricin CD has little impact on most other genera, including many gastrointestinal commensals. Complete amino acid sequencing using infusion tandem mass spectrometry indicated that each peptide is posttranslationally modified at its respective 21st, 25th, and 28th residues. Solution NMR studies on [13C,15N] Trn-α and [13C,15N]Trn-β were used to characterize these modifications. Analysis of multidimensional NOESY data shows that specific cysteines are linked to the α-carbons of the modified residues, forming three sulfur to α-carbon bridges. Complete sequencing of the thuricin CD gene cluster revealed genes capable of encoding two S′-adenosylmethionine proteins that are characteristically associated with unusual posttranslational modifications. Thuricin CD is a two-component antimicrobial peptide system with sulfur to α-carbon linkages, and it may have potential as a targeted therapy in the treatment of CDAD while also reducing collateral impact on the commensal flora.This publication has 30 references indexed in Scilit:
- A new group of parasporal inclusions encoded by the S-layer gene ofBacillus thuringiensisFEMS Microbiology Letters, 2008
- Increase inClostridium difficile–related Mortality Rates, United States, 1999–2004Emerging Infectious Diseases, 2007
- Clostridium difficile: changing epidemiology and new treatment optionsCurrent Opinion in Infectious Diseases, 2007
- Antimicrobial activity of lacticin 3147 against clinical Clostridium difficile strainsJournal of Medical Microbiology, 2007
- Plasmid-mediated bacteriocin production by Shigella flexneri isolated from dysenteric diarrhoea and their transformation into Escherichia coliLetters in Applied Microbiology, 2006
- Bacteriocins: developing innate immunity for foodNature Reviews Microbiology, 2005
- Genomics of the Bacillus cereus group of organismsFEMS Microbiology Reviews, 2005
- Genomics of theBacillus cereusgroup of organismsFEMS Microbiology Reviews, 2005
- Lantibiotics: structure, biosynthesis and mode of actionFEMS Microbiology Reviews, 2001
- Thuricin 7: a novel bacteriocin produced by Bacillus thuringiensis BMG1.7, a new strain isolated from soilLetters in Applied Microbiology, 2001